FIRAPY Debuts at WHX Dubai 2026 with a Focus on Innovative Care for Dialysis Patients

February 12, 2026

On 9–10 February 2026, FIRAPY joined Unex Corporation (Japan) at World Health Expo – WHX Dubai 2026, held at the Dubai Exhibition Centre, Expo City Dubai. This was FIRAPY’s first time participating in WHX Dubai, marking an important step in expanding our presence in the Middle East and surrounding regions.



WHX Dubai (World Health Expo) is one of the region’s most important healthcare exhibitions, bringing together thousands of healthcare professionals, industry leaders, and innovators from more than 100 countries. The event combines a large-scale trade show with conferences and forums that highlight new technologies, clinical best practices, and emerging models of care.


Within the shared exhibition area, FIRAPY and Unex each showcased their own products and solutions.

FIRAPY’s booth focused on the theme:

“An Innovative Therapy for Dialysis Patients”

Visitors could see how FIRAPY is applied in real-world dialysis units through photos, clinical examples, and on-site discussions about workflow integration and patient selection.

Unex, meanwhile, presented its own FMD technologies, giving visitors a broader view of innovation in vascular care coming from Japan and Taiwan.


Strong Interest from Emerging and Established Markets

During the first two days of WHX Dubai, the FIRAPY booth welcomed a continuous stream of visitors, including distributors and potential partners from India, Italy, Pakistan, Morocco, Bosnia and Herzegovina, the United Arab Emirates, Saudi Arabia, Lebanon, and Libya.

Discussions covered:

  • How to introduce FIRAPY as a non-invasive option for vascular access care
  • Integration into existing dialysis workflows and staffing patterns
  • Evidence from international guidelines and clinical studies
  • Opportunities for pilot projects and local clinical evaluation

We were deeply impressed by the energy of the exhibition and the proactive engagement of attendees. Many visitors came prepared with detailed questions about clinical outcomes, patient selection, and implementation in both public and private dialysis centers—turning booth visits into serious, project-oriented conversations.

We are grateful to all the clinicians, distributors, and industry colleagues who visited our booth, and to Unex for sharing the exhibition space in Dubai. FIRAPY remains committed to bringing evidence-based, practical, and patient-friendly FIR therapy to dialysis patients worldwide.

Want to know more?



Contact us for more detail


Learn more
Questions to FIRAPY
August 19, 2026
A new study published in Cells has provided further insight into the molecular responses of arterial endothelial cells following far-infrared (FIR) irradiation.  The study, conducted by researchers from Gunma Paz University, Japan, investigated the effects of FIR on human femoral artery endothelial cells (HFAECs) using an integrated multi-omics approach combining transcriptomics, proteomics, and phosphoproteomics. FIR irradiation was delivered using the WSTM TY101F far-infrared therapy unit manufactured by WS Far Infrared Medical Technology.
FIRAPY at MEDICA 2026 | Innovative Care for Dialysis Patients
August 19, 2026
Meet FIRAPY at MEDICA 2026 in Düsseldorf, November 16–19. Visit Hall 16, Booth B03-2 to explore innovative far infrared therapy for dialysis patient care.
More Posts